Semprini R - Search Results

1

Insulin and the Future Treatment of Alzheimer's Disease.

Semprini R, Koch G, Belli L, Lorenzo FD, Ragonese M, Manenti G, Sorice GP, Martorana A. Semprini R, et al. CNS Neurol Disord Drug Targets. 2016;15(6):660-4. doi: 10.2174/1871527315666160518123049. CNS Neurol Disord Drug Targets. 2016. PMID: 27189471 Review.

2

Ageing as a Trait de Union between diabetes and dementia for frailty.

Semprini R, Ragonese M, Poggi M, Franze A, Martorana A. Semprini R, et al. CNS Neurol Disord Drug Targets. 2013 Jun;12(4):520-4. doi: 10.2174/1871527311312040012. CNS Neurol Disord Drug Targets. 2013. PMID: 23574169

3

Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals.

Martorana A, Di Lorenzo F, Manenti G, Semprini R, Koch G. Martorana A, et al. Among authors: semprini r. Front Aging Neurosci. 2014 Sep 23;6:254. doi: 10.3389/fnagi.2014.00254. eCollection 2014. Front Aging Neurosci. 2014. PMID: 25295005 Free PMC article.

4

Diabetes mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with the APOE4 genotype.

Motta C, Assogna M, Bonomi CG, Mascolo AP, De Lucia V, Semprini R, Mercuri NB, Koch G, Martorana A. Motta C, et al. Among authors: semprini r. Eur J Neurol. 2021 Dec;28(12):3965-3971. doi: 10.1111/ene.15039. Epub 2021 Aug 9. Eur J Neurol. 2021. PMID: 34309155

5

Apathy as marker of frail status.

Semprini R, Lubrano A, Misaggi G, Martorana A. Semprini R, et al. J Aging Res. 2012;2012:436251. doi: 10.1155/2012/436251. Epub 2012 Feb 12. J Aging Res. 2012. PMID: 22500230 Free PMC article.

6

Observational clinical and nerve conduction study on effects of a nutraceutical combination on painful diabetic distal symmetric sensory-motor neuropathy in patients with diabetes type 1 and type 2.

Semprini R, Martorana A, Ragonese M, Motta C. Semprini R, et al. Minerva Med. 2018 Oct;109(5):358-362. doi: 10.23736/S0026-4806.18.05710-5. Minerva Med. 2018. PMID: 30338679

7

Kyphoplasty: a new opportunity for rehabilitation of neurologic disabilities.

Masala S, Tropepi D, Fiori R, Semprini R, Martorana A, Massari F, Bernardi G, Simonetti G. Masala S, et al. Among authors: semprini r. Am J Phys Med Rehabil. 2004 Oct;83(10):810-2. doi: 10.1097/01.phm.0000137319.22908.eb. Am J Phys Med Rehabil. 2004. PMID: 15385794

8

Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study.

Ragonese M, Larosa M, Angotti S, Annese S, Cruciani L, Dainelli M, Lucisano G, Prosperini G, Sacco M, Salomone E, Saponara C, Semprini R, Rossi MC, Nicolucci A. Ragonese M, et al. Among authors: semprini r. Diabetes Ther. 2020 Oct;11(10):2283-2298. doi: 10.1007/s13300-020-00902-1. Epub 2020 Aug 19. Diabetes Ther. 2020. PMID: 32813262 Free PMC article.

9

Age and stage dependency of P300 latency alterations in non-demented Parkinson's disease patients without therapy.

Stanzione P, Semprini R, Pierantozzi M, Santilli AM, Fadda L, Traversa R, Peppe A, Bernardi G. Stanzione P, et al. Among authors: semprini r. Electroencephalogr Clin Neurophysiol. 1998 Jan;108(1):80-91. doi: 10.1016/s0168-5597(97)00070-1. Electroencephalogr Clin Neurophysiol. 1998. PMID: 9474065

10

An electrophysiological study of D2 dopaminergic actions in normal human retina: a tool in Parkinson's disease.

Stanzione P, Traversa R, Pierantozzi M, Semprini R, Marciani MG, Bernardi G. Stanzione P, et al. Among authors: semprini r. Neurosci Lett. 1992 Jun 8;140(1):125-8. doi: 10.1016/0304-3940(92)90697-6. Neurosci Lett. 1992. PMID: 1407691

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters